[News Brief] HSA Updates Brukinsa Prescribing Information on CYP3A Inhibitors
The Health Sciences Authority (HSA) has announced a correction to the Singapore prescribing information for Brukinsa Capsule 80 mg regarding…
The Health Sciences Authority (HSA) has announced a correction to the Singapore prescribing information for Brukinsa Capsule 80 mg regarding…
The Health Sciences Authority (HSA) has advised that the oral formulation of Rhinathiol Promethazine should not be used in children…
GSK has published findings indicating its respiratory syncytial virus (RSV) vaccine Arexvy was associated with reduced risks of certain severe…
ViiV Healthcare has reported that final data from the LATITUDE phase III trial show its long-acting injectable regimen, Cabenuva (cabotegravir…
Otsuka has stated that the U.S. Food and Drug Administration (FDA) has accepted for priority review its New Drug Application…
South Korean healthcare company Kwangdong Pharmaceutical has entered the Singapore market with its Vita500 range of vitamin products, marking an…
The European Commission has approved a 7.2 mg once-weekly maintenance dose of Wegovy® (semaglutide) for adults with obesity across all…
Meiji Seika Pharma Co., Ltd. plans to establish a local subsidiary in Singapore in spring 2026 to strengthen its commercial…
Metagen, Inc. has unveiled its Gut Design Programme in ASEAN at the Global Knowledge Hub Forum in Singapore, aiming to…
Hyphens Pharma has secured exclusive rights from Japan-based Maruho to register and commercialise the shingles treatment Amenalief ® Tab 200…